Moderna reports Covid vaccine is 95% effective, can be stored at higher temperatures

The Cambridge-based biotech firm says an early look at Phase 3 trial data from its Covid-19 vaccine shows it may be more effective than Pfizer’s leading candidate at preventing infection, and also and will be easier to distribute.